Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
This article summarizes the most significant insider buying and selling activities reported for US stocks on Friday, July 13, 2025.
Top Insider Buys:
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX): Chairman and CEO A J Kazimi reported multiple stock purchases between June 2 and June 30, 2025. The total value of the purchases amounted to $807, with prices ranging from $2.6 to $6.0 per share. Kazimi acquired a total of 160 shares through a series of daily transactions executed automatically under a pre-arranged Rule 10b5-1 trading plan. Additionally, director Caroline Young consistently purchased company stock during the same period, acquiring 76 shares for a total of $403.
RENN Fund, Inc. (EXCHANGE:RCG): Murray Stahl, President and Co-Portfolio Manager, acquired 1,126 shares of common stock on July 10, 2025, at a price of $2.68 per share, totaling $3,028. Following the transaction, Stahl directly holds 93,886 shares, with additional indirect holdings through various entities.
Texas Pacific Land Corp (NYSE:TPL): Horizon Kinetics Asset Management LLC, a ten percent owner, purchased 1 share of the company’s common stock on July 10, 2025, at a price of $1039.87 per share.
Butler National Corp (NASDAQ:BUKS): Director Joseph Patrick Daly reported purchasing shares of common stock on July 10, 2025. The purchases, executed with a transaction code "P", totaled $20,837. Daly acquired 2,611 shares at $1.55, 10,000 shares at $1.53, and 1,000 shares at $1.49. On July 9, 2025, Daly also acquired 8,503 shares with a transaction code "A", for a total value of $12,499 at a price of $1.47 per share.
Top Insider Sells:
Appian Corp (NASDAQ:APPN): Abdiel Capital Advisors, L.P., along with related entities, reported selling 289,340 shares of Class A Common Stock between July 9 and July 11, 2025. The sales were executed in multiple transactions, fetching prices ranging from $30.12 to $31.19, totaling approximately $8.96 million.
Astera Labs , Inc. (NASDAQ:ALAB): President and COO Gajendra Sanjay, through trusts, sold a total of 165,000 shares of common stock on July 9, 2025, for approximately $16.2 million. The sales were executed at weighted average prices ranging from $98.2078 to $99.2093.
T-Mobile US, Inc. (NASDAQ:TMUS): Deutsche Telekom AG, a director and ten percent owner, sold 215,230 shares of common stock over three days, from July 9 to July 11, 2025. The sales were executed under a pre-arranged 10b5-1 trading plan, with prices ranging from $226.7587 to $234.8475 per share, resulting in total proceeds of approximately $47.9 million.
Paychex Inc (NASDAQ:PAYX): Director Martin Mucci sold 97,526 shares of common stock on July 10, 2025, for approximately $14.1 million at a price of $145.17 per share. Mucci also exercised options to acquire 435,226 shares and disposed of 310,699 shares to cover tax obligations.
Neurocrine Biosciences Inc (NASDAQ:NBIX): Chief Scientific Officer Jude Onyia sold 59,819 shares of common stock on July 9, 2025, for approximately $7.8 million. The sales were executed at a weighted average price of $130.455.
Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s internal perspective. While insider transactions alone should not be the sole basis for investment decisions, they can serve as an additional data point when evaluating a stock’s potential. It’s important to consider these transactions alongside other fundamental and technical analysis factors to make informed investment choices.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.